Discovering · Developing · Delivering Hope

WIPO WIPO 2021

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke Discovering · Developing · Delivering Hope wurde als Bildmarke am 08.01.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Zeichen, Notationen, Symbole #Briefe, die eine besondere Form des Schreibens darstellen #Punkte

Markendetails Letztes Update: 10. August 2022

Markenform Bildmarke
Aktenzeichen 1581343
Länder Australien Schweiz China Großbritannien Israel Japan Mexiko Norwegen Neuseeland Russland Singapur
Basismarke US Nr. 88186713, 08. November 2018
Anmeldedatum 08. Januar 2021
Ablaufdatum 08. Januar 2031

Markeninhaber

C & H Building, 3rd Floor,
35 Teheran-ro 87-Gil, Gangnam-Gu
KR

Markenvertreter

550 West Adams Street, Suite 300 Chicago IL 60661 US

Waren und Dienstleistungen

41 Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing online publications, not downloadable, in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues via a website
42 Medical and pharmaceutical research for the treatment of cardiac disease and disorders; Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing laboratory testing services for medical research purposes and information in the field of the treatment of cardiac disease and disorders research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and medicine via a website
44 Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues via websites; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing information in the field of health and wellness via a website; providing medical information in the field of cardiac issues via a website; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
08. August 2022 2022/32 Gaz CH Ablehnung
13. Juli 2022 2022/28 Gaz MX Ablehnung
24. März 2022 2022/12 Gaz NO Ablehnung
23. März 2022 2022/14 Gaz SG Ablehnung
28. Februar 2022 2022/10 Gaz CH Ablehnung
27. Januar 2022 2022/4 Gaz JP Ablehnung
10. Januar 2022 2022/7 Gaz IL Ablehnung
02. November 2021 2021/44 Gaz NZ Ablehnung
15. Oktober 2021 2021/42 Gaz NO Ablehnung
17. August 2021 2021/33 Gaz AU Ablehnung
29. Juli 2021 2021/30 Gaz GB Ablehnung
23. Juli 2021 2021/31 Gaz CN Ablehnung
21. Juli 2021 2021/31 Gaz IL Ablehnung
21. Juni 2021 2021/25 Gaz RU Ablehnung
07. Mai 2021 2021/20 Gaz SG Ablehnung
08. Januar 2021 2021/9 Gaz US Eintragung

ID: 141581343